Iron Chelation Resulting in Renal Phosphate Wasting
نویسندگان
چکیده
Lynda Cheddani, Thierry Leblanc, Caroline Silve, Nahid Tabibzadeh, Dominique Prié, Jean-Philippe Haymann, Marie-Noëlle Péraldi, Michel Daudon, Paul Meria and Emmanuel Letavernier Sorbonne Université UPMC Paris 06, UMR S 1155, Paris, France; INSERM, UMR S 1155, Paris, France; Explorations Fonctionnelles Multidisciplinaires, AP-HP, Hôpital Tenon, Paris, France; Service d’Hématologie, AP-HP, Hôpital Saint-Louis, Paris, France; Service de Biochimie et Génétique Moléculaire, AP-HP, Hôpital Cochin, Paris, France; INSERM U1169, Université Paris Sud, Hôpital Bicêtre, Le Kremlin Bicêtre, France; Centre de Référence des Maladies Rares du Métabolisme du Phosphore et du Calcium, Filière de Santé Maladies Rares OSCAR, AP-HP, Paris, France; Paris Descartes Université Paris 05, Paris, France; Service des Explorations Fonctionnelles, AP-HP, Hôpital Necker, Paris, France; Service de Néphrologie, AP-HP, Hôpital Saint-Louis, Paris, France; and Service d’Urologie, AP-HP, Hôpital Saint-Louis, Paris, France
منابع مشابه
Hypophosphatemia: an evidence-based problem-solving approach to clinical cases.
Hypophosphatemia is defined as a serum phosphate level of less than 2.5 mg/dL (0.8 mmol/L). Hypophosphatemia is caused by inadequate intake, decreased intestinal absorption, excessive urinary excretion, or a shift of phosphate from the extracellular to the intracellular compartments. Renal phosphate wasting can result from genetic or acquired renal disorders. Acquired renal phosphate wasting sy...
متن کاملTriple Drug Iron Chelation Therapy in Thalassemia Major; A Case Report
Regular packed cell transfusion in patients with thalassemia major leads to iron overload. Chelation therapy is one of the important aspects of thalassemia care as iron overload causes significant cardiac, hepatic, and endocrine dysfunction. We report a case of thalassemia major with severe iron overload causing cardiac and liver dysfunction who benefitted from triple drug chelation therapy. Tr...
متن کاملA Glance at the Cost of Chelation Therapy with Desferal and Exjade in Iran
Background: Thalassemia is a series of hemoglobinopathies in which the production of perfect hemoglobin is completely or partially suppressed. Using injectable iron chelators have been dominating treatment for the iron overload caused by recurrent blood transfusions in thalassemic patients, however, a new oral iron chelating drug (Exjade) have been recently introduced and might be cost effec...
متن کاملIron chelation via deferoxamine exacerbates experimental salmonellosis via inhibition of the nicotinamide adenine dinucleotide phosphate oxidase-dependent respiratory burst.
Competition for cellular iron (Fe) is a vital component of the interaction between host and intracellular pathogen. The host cell requires Fe for the execution of antimicrobial effector mechanisms, whereas most bacteria have an obligate requirement for Fe to sustain growth and intracellular survival. In this study, we show that chelation of host Fe in vivo exacerbates murine salmonellosis, resu...
متن کاملInhibition of Mitochondrial Aconitase by Succination in Fumarate Hydratase Deficiency
The gene encoding the Krebs cycle enzyme fumarate hydratase (FH) is mutated in hereditary leiomyomatosis and renal cell cancer (HLRCC). Loss of FH activity causes accumulation of intracellular fumarate, which can directly modify cysteine residues to form 2-succinocysteine through succination. We undertook a proteomic-based screen in cells and renal cysts from Fh1 (murine FH)-deficient mice and ...
متن کامل